ILMN Illumina Options Ahead of Earnings Analyzing the options chain and the chart patterns of ILMN Illumina prior to the earnings report this week,
I would consider purchasing the 140usd strike price in the money Calls with
an expiration date of 2024-12-20,
for a premium of approximately $16.65.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
ILMN
ILMN Illumina Options Ahead of EarningsAnalyzing the options chain and the chart patterns of ILMN Illumina prior to the earnings report this week,
I would consider purchasing the 195usd strike price Calls with
an expiration date of 2023-9-15,
for a premium of approximately $8.15.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
$ILMN gapped down provided nice opportunity$ILMN gapped down
Jan 20 190 P were selling for $7.3+ on gap down
Risk reward worth, took stab
#stocks #options
-
Up 50% in a few minutes
But will hold $ILMN Puts, believe it goes higher
Gap @ 204
On the chance we get put, doubt it, but in the chance, it's in a channel 180 - 240
-
Daily in a nice channel
Illuminia ILMN triple bottom reversal breaking out
This could be a triple bottom or an inverse head and shoulders depending on your interpretation. Seems today this broke out of both formations and had a failed attempt to get through a very nearby resistance at $431.19
I'm a buyer with a close at $432 or above but also wouldn't be surprised to see a slight pull back to the head and shoulders line of the $420 range for a second entry opportunity. It should act as a support level now the shape is broken.
For extra encouragement it looks like 21 day and 50 day SMA are due to cross. Also worth waiting for this move to play out before entering. For those of you with a preference for EMA I'm guessing it already crossed but check for yourself.
Lights on bullsHere I drawn some trend lines of support and resistance; they form a bullish triangle, so I will go long on ILMN.
The target price is around the resistance line, but it can continue to reach the maximum price ever. I will close the long position if the support line will be crossed down.
ILMN Stocks for 2021 Looking to Illumina price now that earnings are knocking at the door, as you can see we are in a kind of Rangin Zones for ILMN price, anyway his Fundamental for a long term stil realy valuable in my opinion, We traced some of the most importants keys levels as support and resistence adding just the last trendline we are looking for a breakout or a confirm as a support. Biotechnologys industries are supposed to grow but we always recommend to investors for attention because this market is getting bigger day by day and competitors could be able to take a slice from this Big Profitable Pie.
$PROG is this a likely takeover for $ILMN or $JNJ ?Here is my latest analysis of Progenity, Inc. Possible that Illumina Inc or Johnson and Johnson would want to buy this to protect their portfolio of pre-natal testing products? In either case it could play out.
Genomics ETF --> breakout & measured moveARKG broke out of the parallel channel with strong volume (over 110% tan average 10-day volume).
When there is a break-out, the 5sma tends to be a good rule of thumb to follow the short-term trend; and not lose to much if there is a failed breakout.
RSI shows we are still not overbought at 67; but with strong buying.
Using the bottom level of the parallel channel to calculate a measured move; puts ARKG around $75.
ILMN- Leader in gene sequencingILMN is short-term to mid-term bearish, long term- bullish. Relief bounce is overdue as the selling pressure seems to be overheating and could soon be exhausted.
ILMN is still a leader in gene sequencing with roughly 70% market share, but its short-term prospect is damaged by waning consumer interest and tariff.
Looking for daily close above 275 and weekly close above 300.
Potential short play once the price reverses up to the supply zone.
LLNW gushing resistant at 8.00Hedge Funds Have Never Been This Bullish On Limelight Networks , Inc. ( LLNW )
Asma UL Husna
,Insider Monkey•June 24, 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. In this article we look at what those investors think of Limelight Networks , Inc. (NASDAQ:LLNW).
Limelight Networks , Inc. (NASDAQ:LLNW) was in 19 hedge funds' portfolios at the end of March. LLNW shareholders have witnessed an increase in activity from the world's largest hedge funds in recent months. There were 16 hedge funds in our database with LLNW holdings at the end of the previous quarter. Our calculations also showed that LLNW isn't among the 30 most popular stocks among hedge funds (click for Q1 rankings and see the video for a quick look at the top 5 stocks). Video: Watch our video about the top 5 most popular hedge fund stocks.
ILMN - will it finally break the resistant?Illumina, Inc. ILMN has been gaining from robust segmental growth and increased demand for its products. The company’s focus on partnerships and worldwide expansion to drive growth are expected to contribute further. However, stiff competition and a tough funding environment remain concerns.
Over the past three months, the Zacks Rank #3 (Hold) stock has outperformed its industry. The stock has gained 30.4% compared with the industry’s growth of 18.6%. Meanwhile, the S&P 500 rallied 14.4% in the same time frame.
The renowned life sciences company, which has a market capitalization of $52.93 billion, provides tools and integrated systems for analysis of genetic variation and function. The company projects 11% growth for the next five years and expects to maintain strong segmental performance. Further, it has a trailing four-quarter positive earnings surprise of 19.3%, on average.